For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Amarin Pharmaceuticals Ireland Limited

Calculating rank

USPTO Granted Patents = 141

% Expired Patents = 10.6

CIPO Patents = 2

EPO Patents = 22

Trademarks = 14

Forward Citations = 4,563

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Paresh Soni (120 out of 123 patents)

Mehar Manku (88 out of 107 patents)

Pierre Wicker (87 out of 88 patents)

4. Rene Braeckman (87 out of 88 patents)

5. Ian Osterloh (86 out of 89 patents)

6. Joseph S Zakrzewski (16 out of 17 patents)

7. Jonathan Rowe (5 out of 8 patents)

8. Richard Preston Mason (4 out of 4 patents)

9. Sephy Philip (2 out of 2 patents)

10. William Stirtan (1 out of 1 patent)

11. Anthony Clarke (1 out of 8 patents)

12. Rene Breackman (1 out of 1 patent)

13. George Grandolfi (1 out of 1 patent)

14. Mehar Manku (0 patent)

15. Ian Osterloh (0 patent)

Core Competencies:

Cardiovascular Disease

Triglyceride Reduction

Dyslipidemia Treatment

Heart Failure Prevention

Apolipoprotein C-III

Eicosapentaenoic Acid

Mixed Dyslipidemia

Oxidation Prevention

Statin Therapy

Fish Allergy

High-Sensitivity C-Reactive Protein

Pharmaceutical Composition

141 patents: Sort by Forward Citations

1. 12427134 - Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter (2025-09-30),

2. 12246003 - Methods of reducing the risk of cardiovascular events in a subject (2025-03-11),

3. 12171738 - Compositions and methods for lowering triglycerides (2024-12-24),

4. 11986452 - Methods of reducing the risk of heart failure (2024-05-21),

5. 11717504 - Methods of reducing the risk of cardiovascular events in a subject (2023-08-08),

6. 11712429 - Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity (2023-08-01),

7. 11712428 - Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity (2023-08-01),

8. 11690820 - Methods of treating mixed dyslipidemia (2023-07-04),

9. 11547710 - Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin (2023-01-10),

10. 11464757 - Compositions and methods for lowering triglycerides (2022-10-11),

11. 11446269 - Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids (2022-09-20),

12. 11439618 - Compositions and methods for lowering triglycerides (2022-09-13),

13. 11400069 - Methods of treating mixed dyslipidemia (2022-08-02),

14. 11369582 - Methods of reducing the risk of cardiovascular events in a subject (2022-06-28),

15. 11298333 - Methods of reducing the risk of cardiovascular events in a subject (2022-04-12),

Company Overview

Amarin Pharmaceuticals Ireland Limited is a biopharmaceutical company headquartered in Dublin, specializing in the development of innovative therapies for cardiovascular diseases. The company focuses on addressing critical health issues such as triglyceride reduction and dyslipidemia treatment, aiming to improve heart health and prevent heart failure. Its core technologies include the use of eicosapentaenoic acid and the modulation of apolipoprotein C-III, positioning Amarin at the forefront of cardiovascular therapeutics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

141 Patents

#14 in Dublin

#20 in Ireland

#5,761 in the World

Dublin, Ireland

Amarin Pharmaceuticals Ireland Limited

Forward Citations = 4,563

13 inventors:

Paresh Soni (120 out of 123 patents)

Mehar Manku (88 out of 107 patents)

Pierre Wicker (87 out of 88 patents)

4. Rene Braeckman (87 out of 88 patents)

5. Ian Osterloh (86 out of 89 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amarin Pharmaceuticals Ireland Limited. Retrieved from https://idiyas.com/company/amarin-pharmaceuticals-ireland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…